Ibn initiates coverage of kairos pharma ltd.

Los angeles, nov. 26, 2024 (globe newswire) -- via ibn – kairos pharma ltd. (nyse american: kapa), a clinical-stage biopharmaceutical company focused on advancing innovative oncology therapeutics, has selected ibn, a multifaceted financial news and publishing company for private and public entities, to spearhead its corporate communications efforts.
IBN Ratings Summary
IBN Quant Ranking